Balance Sheet - AbCellera Biologics Inc. (ABCL)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 533.83 | 625.61 | 760.59 | 886.49 | 722.98 | 1,188.23 | 7.55 | 10.44 |
| Accounts receivable, net | 153.40 | 92.13 | 64.38 | 38.59 | 160.58 | 213.73 | 2.12 | 1.40 |
| Inventories | 6.34 | 0.00 | 1.11 | 1.53 | 1.67 | 1.41 | 0.16 | 0.00 |
| Other current assets | 34.67 | 33.63 | 45.91 | 98.88 | 44.58 | 4.07 | 2.80 | 3.31 |
| Total current assets | 728.23 | 751.37 | 871.99 | 1,025.49 | 929.80 | 813.33 | 12.64 | 15.16 |
| Total non-current assets | 628.72 | 609.18 | 616.11 | 515.42 | 388.77 | 192.21 | 10.85 | 6.33 |
| Total assets | 1,356.95 | 1,360.55 | 1,488.09 | 1,540.91 | 1,318.57 | 1,005.54 | 23.49 | 21.49 |
| Total current liabilities | 64.31 | 76.61 | 119.01 | 118.32 | 120.68 | 103.49 | 7.90 | 6.43 |
| Total non-current liabilities | 325.74 | 227.86 | 216.76 | 189.31 | 172.16 | 71.54 | 5.34 | 3.45 |
| Total liabilities | 390.05 | 304.47 | 335.78 | 307.63 | 292.84 | 175.03 | 13.24 | 9.88 |
| Total stockholders' equity | 966.90 | 1,056.08 | 1,152.32 | 1,233.28 | 1,025.73 | 830.51 | 10.25 | 11.61 |
| Common shares outstanding | 299 | 294 | 289 | 315 | 318 | 263 | 238 | 151 |
Show Quarterly Balance Sheet
Balance Sheet - AbCellera Biologics Inc. (ABCL)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 504.73 | 533.83 | 495.67 | 553.08 | 605.27 | 625.61 | 643.14 | 670.36 | 698.02 | 760.59 | 785.84 | 795.69 | 796.50 | 886.49 | 868.21 | 1,022.27 | 786.05 | 722.98 | 753.48 | 835.28 | 717.98 | 594.12 | 685.20 | 132.38 | 7.55 | 601.67 | 0.00 | 0.00 | 10.44 |
| Accounts receivable, net | 115.73 | 153.40 | 159.36 | 153.37 | 126.61 | 92.13 | 63.24 | 67.70 | 68.78 | 64.38 | 75.48 | 86.23 | 99.57 | 103.41 | 105.96 | 52.80 | 334.40 | 160.58 | 43.63 | 65.31 | 23.37 | 213.73 | 5.53 | 0.29 | 14.52 | 2.12 | |||
| Inventories | 7.86 | 6.34 | 0.00 | 0.00 | 0.74 | 1.11 | 1.19 | 1.45 | 1.45 | 1.53 | 25.00 | 25.00 | 25.00 | 1.67 | 1.33 | 1.21 | 1.21 | 1.41 | 1.03 | 0.00 | 0.16 | ||||||||
| Other current assets | 36.28 | 34.67 | 40.11 | 35.70 | 33.10 | 33.63 | 36.51 | 33.50 | 46.41 | 45.91 | 57.00 | 47.36 | 43.14 | 34.06 | 46.50 | 43.89 | 28.92 | 44.58 | 5.30 | 4.92 | 197.61 | 4.07 | 16.36 | 15.27 | 2.80 | ||||
| Total current assets | 664.60 | 728.23 | 695.14 | 742.15 | 764.98 | 751.37 | 742.88 | 771.55 | 813.95 | 871.99 | 919.52 | 930.74 | 940.65 | 1,025.49 | 1,045.67 | 1,143.96 | 1,174.38 | 929.80 | 803.75 | 864.00 | 907.98 | 813.33 | 114.00 | 128.70 | 7.55 | 12.64 | 10.44 | ||
| Total non-current assets | 642.52 | 628.72 | 660.85 | 659.92 | 579.23 | 609.18 | 649.95 | 640.93 | 649.15 | 616.11 | 592.67 | 606.43 | 557.27 | 515.42 | 506.74 | 449.83 | 417.91 | 388.77 | 368.99 | 287.85 | 220.54 | 192.21 | 28.39 | 26.51 | -7.55 | 10.85 | -10.44 | ||
| Total assets | 1,307.11 | 1,356.95 | 1,355.99 | 1,402.06 | 1,344.21 | 1,360.55 | 1,392.83 | 1,412.48 | 1,463.10 | 1,488.09 | 1,512.19 | 1,537.17 | 1,497.92 | 1,540.91 | 1,552.41 | 1,593.78 | 1,592.29 | 1,318.57 | 1,172.73 | 1,151.86 | 1,128.52 | 1,005.54 | 142.39 | 155.22 | 23.49 | ||||
| Total current liabilities | 47.29 | 64.31 | 68.80 | 67.02 | 75.40 | 76.61 | 79.57 | 70.38 | 104.88 | 119.01 | 110.24 | 118.91 | 89.59 | 118.32 | 106.05 | 221.14 | 213.42 | 120.68 | 49.55 | 69.76 | 88.40 | 103.49 | 20.10 | 18.27 | 18.27 | 7.90 | |||
| Total non-current liabilities | 321.74 | 325.74 | 323.15 | 327.96 | 245.83 | 227.86 | 235.17 | 231.13 | 228.30 | 216.76 | 219.18 | 223.43 | 199.83 | 189.31 | 196.19 | 159.79 | 171.36 | 172.16 | 169.79 | 114.42 | 83.00 | 71.54 | 33.04 | 46.05 | 5.34 | ||||
| Total liabilities | 369.03 | 390.05 | 391.95 | 394.99 | 321.23 | 304.47 | 314.73 | 301.51 | 333.18 | 335.78 | 329.42 | 342.34 | 289.42 | 307.63 | 302.24 | 380.93 | 384.78 | 292.84 | 219.34 | 184.18 | 171.40 | 175.03 | 53.15 | 64.32 | 13.24 | ||||
| Total stockholders' equity | 938.08 | 966.90 | 964.04 | 1,007.08 | 1,022.98 | 1,056.08 | 1,078.09 | 1,110.97 | 1,129.91 | 1,152.32 | 1,182.78 | 1,194.83 | 1,208.50 | 1,233.28 | 1,250.17 | 1,212.86 | 1,207.51 | 1,025.73 | 953.40 | 967.68 | 957.12 | 830.51 | 89.24 | 90.89 | 10.25 | 10.25 | 11.61 | ||
| Common shares outstanding | 303 | 299 | 299 | 299 | 298 | 295 | 295 | 294 | 293 | 291 | 289 | 289 | 288 | 301 | 316 | 285 | 311 | 315 | 279 | 272 | 320 | 320 | 266 | 238 | 238 | 238 | 152 | 151 | 151 |